J&J Will Pay $120M To Settle State Hip Claims
Johnson & Johnson will pay $120m to settle allegations the company misled consumers about metal-on-metal hip implants under an agreement reached with 46 state attorneys general.
You may also be interested in...
The bellwether case resulted in a jury award of $1b to a group of six California patients who say they were injured by the metal-on-metal hip. J&J plans to appeal.
A group of manufacturers and clinicians is asking the US agency to allow more discussion between manufacturers, labs and clinicians of how genetic factors could influence drug effectiveness – an area known as pharmacogenomics (PGx). The FDA had previously taken several steps to limit these communications.
The US FDA says Bayer has successfully recovered unsold Essure units and completed enrollment in a Sec. 522 postmarket study, fulfilling deadlines set at a year from the date the devices were taken off the US market.